News Detail

Argenx, ServiceNow And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Benzinga · 12/15/2025 13:06

Listen to the news

U.S. stock futures were higher this morning, with the Dow futures gaining around 200 points on Monday.

Shares of argenx SE – ADR (NASDAQ:ARGX) fell sharply in pre-market trading after the company discontinued its Phase 3 UplighTED studies of efgartigimod SC in thyroid eye disease following a futility review.

argenx shares dipped 6% to $825.00 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

TryHard Holdings Ltd (NASDAQ:THH) shares tumbled 15.2% to $13.16 in pre-market trading after jumping 58% on Friday.
Site Centers Corp (NYSE:SITC) declined 13.4% to $6.33 in pre-market trading.
Exicure Inc (NASDAQ:XCUR) dipped 8.7% to $5.80 in pre-market trading after gaining 5% on Friday.
Celldex Therapeutics Inc (NASDAQ:CLDX) declined 8.4% to $25.19 in pre-market trading.
CapsoVision Inc (NASDAQ:CV) fell 6.4% to $12.03 in pre-market trading after declining around 11% on Friday.
Zillow Group Inc (NASDAQ:Z) fell 5.6% to $70.50 in pre-market trading.
BeOne Medicines AG (NASDAQ:ONC) declined 4.9% to $303.50 in pre-market trading.
ServiceNow Inc (NYSE:NOW) fell 4.7% to $824.50 in pre-market trading after KeyBanc downgraded the stock to Underweight.
WaterBridge Infrastructure LLC (NYSE:WBI) fell 4.4% to $20.05 in pre-market trading.
Pharming Group N V (NASDAQ:PHAR) declined 4.2% to $17.23 in pre-market trading.

Now Read This:

Top 2 Energy Stocks That May Plunge This Month

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.